Relationship between paraoxonase-1 activity, carotid intima-media thickness and arterial stiffness in hypertensive patients.
Yang
W-I
WI
Lee
S-H
SH
Ko
Y-G
YG
Kang
S-M
SM
Choi
D
D
Ha
J-W
JW
Hong
M-K
MK
Chung
N
N
Shim
W-H
WH
Cho
S-Y
SY
Jang
Y
Y
D000367:Age Factors; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D043303:Aryldialkylphosphatase / Q000032:analysis / Q000378:metabolism*; D050197:Atherosclerosis / Q000201:enzymology / Q000473:pathology; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002339:Carotid Arteries / Q000201:enzymology / Q000473:pathology*; D050171:Dyslipidemias / Q000188:drug therapy / Q000201:enzymology; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy / Q000201:enzymology / Q000473:pathology*; D008297:Male; D017539:Tunica Intima / Q000201:enzymology / Q000473:pathology*
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D043303:Aryldialkylphosphatase; C468406:PON1 protein, human